- Home
- XRTX vs BNBX Comparison
XRTX vs BNBX Comparison
Compare XRTX & BNBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XRTX | BNBX |
|---|---|---|
| Founded | 2011 | 1983 |
| Country | Canada | United States |
| Employees | 3 | 26 |
| Industry | Pharmaceuticals and Biotechnology | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2M | 3.6M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | XRTX | BNBX |
|---|---|---|
| Price | $3.02 | $0.52 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 375.2K |
| Earning Date | 05-15-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $253.12 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.35 | $0.47 |
| 52 Week High | $3.60 | $6.17 |
Technical Indicators
Market Signals| Indicator | XRTX | BNBX |
|---|---|---|
| Relative Strength Index (RSI) | 74.24 | 30.56 |
| Support Level | $0.52 | N/A |
| Resistance Level | N/A | $0.82 |
| Average True Range (ATR) | 0.37 | 0.08 |
| MACD | 0.06 | -0.00 |
| Stochastic Oscillator | 64.78 | 12.23 |
Price Performance
Historical ComparisonAbout XRTX XORTX Therapeutics Inc.
XORTX Therapeutics Inc is a clinical-stage pharmaceutical company focused on developing therapies to treat gout and progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications such as allopurinol-intolerant gout and autosomal dominant polycystic kidney disease, as well as more prevalent type 2 diabetic nephropathy and fatty liver disease. Its focus is on developing products to slow and/or reverse the progression of these diseases. The Company operates in one reportable operating segment: the development and commercialization of therapies to treat hyperuricemia-related diseases.
About BNBX Applied DNA Sciences Inc.
BNB Plus Corp focuses on digital asset treasury management of BNB. The group is unlocking institutional-grade access to the Binance ecosystem, delivering non-directional yield strategies and long BNB exposure, powering the future of blockchain through a transparent, actively managed BNB treasury. The Company's differentiated blends sophisticated DeFi yield generation with Binance-native opportunities, unlocking access to high-performance digital assets for investors traditionally excluded from the space.